Evidence map›Paper›PMID 42467527›Full record

Observational studyUltrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology2026

Hypertension at 5 months postpartum in women with gestational diabetes.

C Gómez Fernández, M Charakida, M Moser, R Breiviene, T Mansukhani, L A Magee, P von Dadelszen, K H Nicolaides

Abstract readObservational Study
In one paragraph

Observational study in Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

C Gómez FernándezHarris Birthright Research Centre for Fetal Medicine, King's College Hospital, London, UK.ORCID https://orcid.org/0000-0001-9359-997X
M CharakidaHarris Birthright Research Centre for Fetal Medicine, King's College Hospital, London, UK.ORCID https://orcid.org/0000-0003-4214-5059
M MoserHarris Birthright Research Centre for Fetal Medicine, King's College Hospital, London, UK.
R BreivieneHarris Birthright Research Centre for Fetal Medicine, King's College Hospital, London, UK.
T MansukhaniHarris Birthright Research Centre for Fetal Medicine, King's College Hospital, London, UK.
L A MageeDepartment of Women and Children's Health, School of Life Course and Population Sciences, King's College London, London, UK.ORCID https://orcid.org/0000-0002-1355-610X
P von DadelszenDepartment of Women and Children's Health, School of Life Course and Population Sciences, King's College London, London, UK.ORCID https://orcid.org/0000-0003-4136-3070
K H NicolaidesHarris Birthright Research Centre for Fetal Medicine, King's College Hospital, London, UK.ORCID https://orcid.org/0000-0003-1266-0711

Funding

Fetal Medicine Foundation
6 · The paper itself

Abstract

objectiveGestational diabetes mellitus (GDM) is associated with future maternal cardiovascular disease, independent of the development of Type-2 diabetes mellitus. As a major cardiovascular risk factor, we examined the incidence and predictors of hypertension at 5 months postpartum in women with previous GDM.

methodsBetween September 2023 and January 2025, we conducted a single-center observational prospective cohort study of all women who received routine prenatal care at 12 weeks' gestation at King's College Hospital, London, UK, and developed GDM during the index pregnancy. Those with chronic hypertension were excluded from the analysis. Women were invited to a 5-month postpartum visit, at which assessment was undertaken for hypertension (systolic blood pressure (BP) ≥ 130 mmHg or diastolic BP ≥ 80 mmHg, or receiving antihypertensive treatment), obesity, adiposity, dysglycemia, dyslipidemia and renal dysfunction. Logistic regression was performed to assess predictors of postnatal hypertension.

resultsAmong the 678 included women with previous GDM in the index pregnancy, 179 (26.4%) developed hypertension at a median of 5.1 (interquartile range (IQR), 4.4-6.7) months postpartum. Multivariable analysis showed that postpartum hypertension was associated with: higher maternal age, Black or mixed ethnicity, higher median weight in early pregnancy, higher systolic and diastolic blood pressure in early pregnancy, and development of pre-eclampsia (PE) or gestational hypertension (GH) in the index pregnancy. The area under the receiver-operating-characteristics curve for the prediction of postpartum hypertension was 0.72 (95% CI, 0.68-0.77) without inclusion of development of PE or GH, and 0.74 (95% CI, 0.70-0.78) with their inclusion. The corresponding detection rates for postpartum hypertension were 49.5% and 53.7%, respectively, at a 20% false-positive rate. Notably, women with GDM in the index pregnancy frequently had dysglycemia (351/678 (51.8%)) as well as body mass index ≥ 30 kg/m

conclusionOne in four women with recent GDM developed hypertension at 5 months postpartum. However, risk prediction from factors observed in early pregnancy was only modest, reinforcing the need for universal postpartum BP assessment. The high prevalence of hypertension and other cardio-renal-metabolic abnormalities following GDM emphasizes the associated enhanced cardiovascular risk, and the postnatal opportunities for intervention early in the life course of these women. © 2026 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

Indexed as

Diabetes, GestationalHypertensionPuerperal DisordersAdultFemaleHumansIncidenceLondonPostpartum PeriodPregnancyProspective StudiesRisk Factorsadipositydiastolic dysfunctiondysglycemiadyslipidemiaechocardiographyhypertension

Identifiers

PMID42467527
PMCPMC13432981

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.